These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 9815803)
1. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1. Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803 [TBL] [Abstract][Full Text] [Related]
2. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909 [TBL] [Abstract][Full Text] [Related]
3. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Martinsson T; Sjöberg RM; Hedborg F; Kogner P Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654 [TBL] [Abstract][Full Text] [Related]
4. Analysis of genomic imprinting at 1p35-36 in neuroblastoma. Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108 [TBL] [Abstract][Full Text] [Related]
7. Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma. Theobald M; Christiansen H; Schmidt A; Melekian B; Wolkewitz N; Christiansen NM; Brinkschmidt C; Berthold F; Lampert F Genes Chromosomes Cancer; 1999 Sep; 26(1):40-6. PubMed ID: 10441004 [TBL] [Abstract][Full Text] [Related]
8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190 [TBL] [Abstract][Full Text] [Related]
10. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646 [TBL] [Abstract][Full Text] [Related]
11. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity for chromosome 14q in neuroblastoma. Thompson PM; Seifried BA; Kyemba SK; Jensen SJ; Guo C; Maris JM; Brodeur GM; Stram DO; Seeger RC; Gerbing R; Matthay KK; Matise TC; White PS Med Pediatr Oncol; 2001 Jan; 36(1):28-31. PubMed ID: 11464899 [TBL] [Abstract][Full Text] [Related]
13. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Gehring M; Berthold F; Edler L; Schwab M; Amler LC Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602 [TBL] [Abstract][Full Text] [Related]
14. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908 [TBL] [Abstract][Full Text] [Related]
15. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis. Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802 [TBL] [Abstract][Full Text] [Related]
17. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897 [TBL] [Abstract][Full Text] [Related]
18. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193 [TBL] [Abstract][Full Text] [Related]
19. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore. Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166 [TBL] [Abstract][Full Text] [Related]
20. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group. Christiansen H; Delattre O; Fuchs S; Theobald M; Christiansen NM; Berthold F; Lampert F Prog Clin Biol Res; 1994; 385():19-25. PubMed ID: 7972212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]